• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Implementation of sodium-glucose cotransporter 2 inhibitors for heart failure with reduced ejection fraction: Where we are versus where we need to be.

作者信息

Pierce Jacob B, Butler Javed, Greene Stephen J

机构信息

Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

Baylor Scott and White Research Institute, Dallas, TX, USA.

出版信息

Eur J Heart Fail. 2023 Sep;25(9):1659-1662. doi: 10.1002/ejhf.2999. Epub 2023 Aug 22.

DOI:10.1002/ejhf.2999
PMID:37581237
Abstract
摘要

相似文献

1
Implementation of sodium-glucose cotransporter 2 inhibitors for heart failure with reduced ejection fraction: Where we are versus where we need to be.钠-葡萄糖协同转运蛋白2抑制剂在射血分数降低的心力衰竭中的应用：我们所处的位置与我们需要达到的位置。
Eur J Heart Fail. 2023 Sep;25(9):1659-1662. doi: 10.1002/ejhf.2999. Epub 2023 Aug 22.
2
Implementing Sodium-Glucose Cotransporter-2 Inhibitor Therapy for Heart Failure: What Is the Message to DELIVER?实施钠-葡萄糖协同转运蛋白2抑制剂治疗心力衰竭：传递的信息是什么？
J Am Coll Cardiol. 2022 Nov 8;80(19):1785-1787. doi: 10.1016/j.jacc.2022.09.008.
3
Sodium-glucose cotransporter 2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: time to deliver implementation.用于射血分数轻度降低或保留的心力衰竭的钠-葡萄糖协同转运蛋白2抑制剂：是时候实施了。
Eur J Heart Fail. 2022 Oct;24(10):1902-1905. doi: 10.1002/ejhf.2688. Epub 2022 Sep 26.
4
The gap between real-world and guidelines in the use of sodium-glucose cotransporter 2 inhibitors for heart failure patients with reduced ejection fraction: Is it underestimated or overestimated? Letter regarding the article 'Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry'.
Eur J Heart Fail. 2024 Mar;26(3):704-705. doi: 10.1002/ejhf.3163. Epub 2024 Feb 8.
5
Sodium-glucose cotransporter-2 inhibitors for heart failure with reduced ejection fraction.用于射血分数降低的心力衰竭的钠-葡萄糖协同转运蛋白2抑制剂。
Can Fam Physician. 2021 Sep;67(9):678. doi: 10.46747/cfp.6709678.
6
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction-Reply.确定射血分数降低的心力衰竭住院患者启动钠-葡萄糖协同转运蛋白2抑制剂治疗的障碍——回复
JAMA Cardiol. 2023 Dec 1;8(12):1188-1189. doi: 10.1001/jamacardio.2023.3784.
7
Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure and Preserved Ejection Fraction-Living on the Edge.钠-葡萄糖协同转运蛋白2抑制剂对射血分数保留的心力衰竭患者的成本效益——处于边缘状态。
JAMA Cardiol. 2023 May 1;8(5):415-416. doi: 10.1001/jamacardio.2023.0087.
8
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.识别射血分数降低的心力衰竭住院患者启动钠-葡萄糖协同转运蛋白-2抑制剂治疗的障碍。
JAMA Cardiol. 2023 Dec 1;8(12):1188. doi: 10.1001/jamacardio.2023.3781.
9
Effects of sodium-glucose cotransporter-2 inhibitors on nutritional status in heart failure with reduced ejection fraction.钠-葡萄糖共转运蛋白 2 抑制剂对射血分数降低的心力衰竭患者营养状况的影响。
Rev Assoc Med Bras (1992). 2022 Nov 28;68(11):1576-1581. doi: 10.1590/1806-9282.20220737. eCollection 2022.
10
Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: Treat the heart, cherish the kidney.射血分数保留的心力衰竭中钠-葡萄糖协同转运蛋白2抑制剂：治疗心脏，爱护肾脏。
Eur J Heart Fail. 2023 Aug;25(8):1349-1351. doi: 10.1002/ejhf.2963. Epub 2023 Jul 17.

引用本文的文献

1
A Human Engineered Heart Tissue-Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin.一种源自人工程心脏组织的脂毒性糖尿病心肌病模型揭示了恩格列净的早期益处。
Adv Sci (Weinh). 2025 Aug;12(30):e03173. doi: 10.1002/advs.202503173. Epub 2025 May 28.
2
Single-nucleus RNA sequencing identifies cell-type-specific effects of sodium-glucose co-transporter 2 inhibitors in human myocardial slices.单核RNA测序确定了钠-葡萄糖协同转运蛋白2抑制剂在人心肌切片中的细胞类型特异性作用。
Eur Heart J. 2024 Sep 14;45(35):3292-3295. doi: 10.1093/eurheartj/ehae472.